GILDER GAGNON HOWE & CO LLC – Denali Therapeutics Inc. Transaction History
GILDER GAGNON HOWE & CO LLC portfolio value:
$57.18M
portfolio value
GILDER GAGNON HOWE & CO LLC quarter portfolio value change:
+4.28%
quarter
Denali Therapeutics Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -4.78% | -93.54K shares | -405K | $30.69 | 1.86M |
Q2 2022 | share | Decrease | -25.29% | -662.39K shares | -26.67M | $29.43 | 1.95M |
Q1 2022 | share | Decrease | -9.69% | -280.89K shares | -45.08M | $32.17 | 2.61M |
Q4 2021 | share | Increase | +3.46% | 97.12K shares | -12.06M | $45.05 | 2.90M |
Q3 2021 | share | Decrease | -1.15% | -32.73K shares | -81.02M | $50.45 | 2.80M |
Q2 2021 | share | Decrease | -5.62% | -168.82K shares | 50.87M | $78.44 | 2.83M |
Q1 2021 | share | Decrease | -6.69% | -215.29K shares | -98.13M | $57.1 | 3.00M |
Q4 2020 | share | Decrease | -2.90% | -96.28K shares | 150.87M | $83.76 | 3.21M |
Q3 2020 | share | Decrease | -2.04% | -69.10K shares | 36.96M | $35.83 | 3.31M |
Q2 2020 | share | Increase | +3.81% | 124.21K shares | 24.75M | $24.18 | 3.38M |
Q1 2020 | share | Increase | 0.00% | 3.26M shares | 57.1M | $17.51 | 3.26M |
Q2 2019 | share | Decrease | -100.00% | -596 shares | -14K | $20.76 | 0 |
Q1 2019 | share | Decrease | -24.27% | -191 shares | -2K | $23.22 | 596 |
Q4 2018 | share | Decrease | -93.86% | -12.02K shares | -262K | $20.66 | 787 |
Q3 2018 | share | Decrease | -5.93% | -808 shares | 70K | $21.74 | 12.80K |
Q2 2018 | share | Decrease | -0.49% | -67 shares | -61K | $15.25 | 13.61K |
Q1 2018 | share | Decrease | -9.56% | -1.44K shares | 32K | $19.69 | 13.68K |
Q4 2017 | share | Increase | 0.00% | 15.13K shares | 237K | $15.64 | 15.13K |